PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

51 hedge funds and large institutions have $60.7M invested in Invesco Biotechnology & Genome ETF in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+11
Holders Change %
+27.5%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
13
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NCM
1
Niemann Capital Management
Nevada
$3.53M
2
Morgan Stanley
2
Morgan Stanley
New York
$16.2M
3
PFG
3
Pacific Financial Group
Washington
$1.99M
4
LPL Financial
4
LPL Financial
California
$2.45M
5
WA
5
WFG Advisors
Texas
$926K

Top Sellers

1
GC
1
Guggenheim Capital
Illinois
$0
2
SAM
2
SignalPoint Asset Management
Missouri
$1.89M
3
Commonwealth Equity Services
3
Commonwealth Equity Services
Massachusetts
$790K
4
WB
4
Webster Bank
Connecticut
$1.62M
5
RJA
5
Raymond James & Associates
Florida
$612K
Name Holding Trade Value Shares
Change 		Shares
Change %
HR
51
Howe & Rusling
New York
$1K – – –
GC
52
Guggenheim Capital
Illinois
– -$1.31M -45,403 Closed
Northwestern Mutual Wealth Management
53
Northwestern Mutual Wealth Management
Wisconsin
– -$23K -800 Closed
T
54
Thomaspartners
Massachusetts
– -$6K -200 Closed
1 2
3